Darbepoetin alfa (Aranesp)

Also known as epo or erythropoetin.

General information

Class/mechanism: Erythropoiesis-stimulating agent (ESA), stimulates division and differentiation of erythroid precursors.
Route: SC, IV
Extravasation: no information

• ESA APPRISE Risk Evaluation and Mitigation Strategy (REMS) Program

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.

Patient drug information

• Darbepoetin alfa (Aranesp) patient drug information (UpToDate)